Salute e Benessere

DELSITECH ANNOUNCES A MAJOR LICENSING AGREEMENT ON DRUG DELIVERY

"We are excited to announce the second license agreement in the first half of 2024 with a global pharmaceutical partner," said Lasse Leino, Chief Executive Officer at DelSiTech. "These successes continue to validate our sustained hard work for the benefit of patients in need of vital new therapies." "We are excited to announce the second license agreement in the first half of 2024 with a global pharmaceutical partner," said Lasse Leino, Chief Executive Officer at…
PR Newswire
23/05/2024

Information on the Total Number of Voting Rights (Denominator) following…

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential market opportunities of USD 3-6 billion...
Nasdaq GlobeNewswire
23/05/2024

Calliditas Q1 report, January - March 2024

JANUARY - MARCH 2024 (COMPARED TO JANUARY - MARCH 2023) JANUARY -MARCH 2024(COMPARED TO JANUARY -MARCH 2023 ) "In Q1 we generated another record quarter in terms of demand with 705 enrollments and 354 new prescribers. We are very excited over this positive trend, and we continue to see strong demand in Q2 ." - CEO Renée Aguiar-Lucander. KEY TAKEAWAYS FROM Q1, 2024 KEY EVENTS AFTER THE REPORTING PERIOD KEY...
PR Newswire
23/05/2024

ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX ®SystemSuccessfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May23, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today provided a Q1 2024 business update.“This...
Nasdaq GlobeNewswire
23/05/2024

Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders

Allschwil, Switzerland – May 23, 2024Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the Annual Report of the year ending December 31, 2023, will be held on Thursday, June 13, 2024, at 09.00 CEST at the Congress Center, Messe Basel, Switzerland. Notes to ShareholdersThe invitation was published in the Swiss Official Gazette of Commerce (Schweizerisches...
Nasdaq GlobeNewswire
23/05/2024

EUROAPI strengthens its presence in animal health with a €130-150 million supply…

Press Release A 5-year manufacturing contract to support the FOCUS-27 project sales trajectoryThis contract highlights EUROAPI's know-how and the reliability of its premium Contract Manufacturing Organization services to customersParis – May 23, 2024– EUROAPI announces today that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key...
Nasdaq GlobeNewswire
23/05/2024

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data…

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Additional kidney function analyses strongly support Vivoryon's shift in strategic focus to inflammatory and fibrotic diseases, and are a further step towards securing Company's futureVaroglutamstat`s beneficial effect of improving kidney function, as demonstrated by an increase of estimated glomerular filtration rate (eGFR), confirmed by various sensitivity...
Nasdaq GlobeNewswire
23/05/2024

IBA Business Update – First Quarter 2024

Louvain-la-Neuve, Belgium, 23 May 2024- IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the first quarter ending 31 March 2024.Group OverviewGood Group order intake at end of March, driven by continued growth in Other Accelerators, with typical strong second half weighting expectedGroup backlog remains at a high of EUR 1.4 billionEUR 30.1 million net cash position, decreasing as a result of a planned...
Nasdaq GlobeNewswire
23/05/2024

Bulletin from the Annual General Meeting of Implantica AG

The general meeting resolved to carry forward the net loss for the financial year 2023 in accordance with the adopted balance sheet and to no payment of dividend. The general meeting resolved to carry forward the net loss for the financial year 2023 in accordance with the adopted balance sheet and to no payment of dividend. The general meeting resolved to discharge the members of the board of directors, the executive management and the auditors from liability for their services in the...
PR Newswire
23/05/2024

CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Register Stunning…

Key Takeaways from the CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Report Key Takeaways from the CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Report Discover which therapies are expected to grab the major CAR T-Cell therapy for ALL market share @CAR T-Cell therapy for ALL Market Report CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Overview Acute lymphocytic leukemia (ALL), alternatively known as acute lymphoblastic leukemia, is a form of...
PR Newswire
22/05/2024

Nyxoah Announces Reduction of the Maximum Amount Available Under its At…

REGULATED INFORMATION INSIDE INFORMATIONNyxoah Announces Reduction of the Maximum Amount Available Under its At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – May 22, 2024, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today that it has reduced the maximum amount...
Nasdaq GlobeNewswire
22/05/2024

Nyxoah Announces Proposed Offering of Ordinary Shares

REGULATED INFORMATION INSIDE INFORMATIONNyxoah Announces Proposed Offering of Ordinary SharesMont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the commencement of a proposed underwritten public offering in the United States, which may...
Nasdaq GlobeNewswire
22/05/2024

Inventiva announces two scientific presentations at the EASL International Liver…

The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients with MASH/NASH, in the NATIVE Phase IIb clinical trial.The second abstract brings additional evidence supporting the role of intrahepatic vascular alterations in the development of MASLD-related portal hypertension and the progression to MASH and highlights the potential of lanifibranor...
Nasdaq GlobeNewswire
22/05/2024

The US Sleep Supplements Market is Set to Reach $1.45 Billion by 2029 -…

The US Sleep Supplements Market Report Scope The US Sleep Supplements Market Report Scope The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this trend. The convenience of online purchasing has made sleep supplements more accessible, while the...
PR Newswire
22/05/2024

The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Specialty…

The U.S. Neonatal Incubators Market Report Scope The U.S. Neonatal Incubators Market Report Scope The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the presence of well-established NICUs and neonatal care, the US market is likely to witness...
PR Newswire
22/05/2024

Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and…

The US Pool Maintenance and Cleaning Service Market Report Scope The US Pool Maintenance and Cleaning Service Market Report Scope The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand for custom maintenance plans, growth in tourism...
PR Newswire
22/05/2024

GENFIT: May 22, 2024 Combined Shareholders Meeting Results

Quorum of 27.25% on first convening; allowing approval of all the resolutionsLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2024-GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the results of the Combined Shareholders Meeting which took place on May 22, 2024. The quorum on first convening amounted to 27...
Nasdaq GlobeNewswire
22/05/2024

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the…

NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics-- Agreement brings together Guerbet's industry leading expertise in medical imaging technologies, production, and commercialization with Nuclidium's in depth know-how of the copper radioisotope production and theranostic development --Basel, Switzerland and Villepinte, France, May 22, 2024–NUCLIDIUMandGuerbet (GBT)today announced a strategic partnership to...
Nasdaq GlobeNewswire
22/05/2024

Groupe Casino : Achats d'actions

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 395 740 444,29 € Siège social : 1, Cours Antoine Guichard 42000 SAINT-ETIENNE 554 501 171 R.C.S. SAINT-ETIENNECommuniqué relatif aux achats d'actions effectués dans les conditionsde l'article 5 du Règlement européen n° 596/2014 Le 20 mai 2024, la société Casino, Guichard-Perrachon a racheté 611 200 actions au prix moyende 0,0392 € dans le cadre de la couverture des plans d'actions gratuites attribuées préalablement à...
Nasdaq GlobeNewswire
22/05/2024

Combined General Meeting of May 22, 2024

Press Release Approval of all resolutions put forward by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2023Ratification of the co-option of Géraldine Leveau as a DirectorParis – May 22, 2024– The Combined General Shareholders' Meeting of EUROAPI was held on May 22, 2024 in Paris, under the chairwomanship of Viviane Monges, and was attended by all directors. All resolutions put forth to a vote were adopted...
Nasdaq GlobeNewswire
22/05/2024

Smartee Empowers the Next Generation of Orthodontists at the 2nd HADO Exhibition

During the exhibition, the Smartee booth attracted a steady stream of visitors eager to explore Smartee's unique innovations and solutions, particularly the Smartee GS mandibular repositioning solutions of S8, S9, S10, and S11. Smartee's commitment to innovation and excellence in orthodontic care resonates deeply with HADO's mission to empower the next generation of orthodontic professionals. During the exhibition, the Smartee booth attracted a steady stream of visitors eager to explore...
PR Newswire
22/05/2024

X-Ray Detectors Market to be Worth $4.81 Billion by 2031 - Exclusive Report by…

X-ray detectors are used to detect primary and secondary X-ray radiation and analyze the spatial distribution, spectrum, flux, and several other properties of X-rays. These detectors are used in X-ray systems with wide applications in the medical, industrial, dental, veterinary, and security industries. X-ray detectors are used to detect primary and secondary X-ray radiation and analyze the spatial distribution, spectrum, flux, and several other properties of X-rays. These detectors are used…
PR Newswire
22/05/2024

Inherited Retinal Disease Market Size and Share to Grow by 2034, Assesses…

Key Takeaways from the Inherited Retinal Disease Market Report Key Takeaways from the Inherited Retinal Disease Market Report Discover which therapies are expected to grab the major inherited retinal disease market share @Inherited Retinal Disease Market Report Inherited Retinal Disease Overview Inherited retinal diseases (IRDs) encompass a diverse range of disorders marked by either the degeneration or malfunction of photoreceptors. These conditions often lead to...
PR Newswire
22/05/2024

Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers…

Key abstracts accepted and presented at ATS included: Key abstracts accepted and presented at ATS included: About Brainomix Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in stroke and lung fibrosis. With origins as a spin-out from the University ofOxford, Brainomix is an expanding commercial-stage company with offices in the UK,Irelandand theUSA, and operations in more than 30 countries...
PR Newswire
22/05/2024
Altri  Comunicati